Which of the following results in a diagnosis of Acquired Immune Deficiency Syndrome (AIDS): a CD4 (Cluster of Differentiation 4) count greater than 500 cells per microliter, seroconversion for Human Immunodeficiency Virus (HIV) antibody, a significant increase in the CD4:CD8 (Cluster of Differentiation 8) ratio, or a CD4 count of 190 cells per microliter and Pneumocystic (Pneumocystis jirovecii pneumonia) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CD4 Count of 190 cells/μL with Pneumocystis Infection Results in AIDS Diagnosis

A CD4 count of 190 cells per microliter with Pneumocystis infection definitively results in a diagnosis of AIDS. 1

Understanding AIDS Diagnosis Criteria

AIDS diagnosis is based on specific immunological and clinical parameters:

  • CD4 count below 200 cells/μL is a critical threshold that indicates severe immunodeficiency and is one criterion for AIDS diagnosis 1
  • The presence of opportunistic infections like Pneumocystis pneumonia (PCP) in HIV-infected individuals is an AIDS-defining illness, regardless of CD4 count 1
  • The combination of both a CD4 count below 200 cells/μL (190 in this case) AND Pneumocystis infection represents clear evidence of advanced HIV disease meeting AIDS definition criteria 1

Why the Other Options Do Not Result in AIDS Diagnosis

  • CD4 levels greater than 500 cells/μL: This represents relatively preserved immune function and does not meet AIDS criteria 1
  • Seroconversion for HIV antibody: This indicates HIV infection but not AIDS; it's typically an early event in HIV infection before immunodeficiency develops 1
  • Significant increase in CD4:CD8 ratio: This would actually suggest immune recovery rather than deterioration; AIDS is characterized by a decreased CD4:CD8 ratio 1

The Relationship Between CD4 Counts and Opportunistic Infections

  • CD4 counts below 200 cells/μL significantly increase the risk of Pneumocystis pneumonia and other opportunistic infections 1
  • HIV-infected patients with CD4 counts below 200 cells/μL should be suspected of having Pneumocystis pneumonia when presenting with respiratory symptoms 1
  • Even in non-HIV immunocompromised patients, CD4 counts below 200 cells/μL are associated with increased PCP risk 2

Clinical Implications

  • Patients with CD4 counts below 200 cells/μL require prophylaxis against Pneumocystis pneumonia 1
  • The presence of Pneumocystis infection in a patient with a CD4 count of 190 cells/μL indicates the need for:
    • Immediate treatment of the acute infection 1
    • Initiation of antiretroviral therapy 3, 4
    • Long-term prophylaxis against recurrent PCP 1

Important Clinical Caveat

  • While a CD4 count below 200 cells/μL alone is sufficient for an AIDS diagnosis according to CDC classification, the presence of an AIDS-defining illness like Pneumocystis pneumonia provides additional confirmation of advanced disease 1
  • The mortality risk remains elevated even after successful viral suppression in patients with low CD4 counts, highlighting the importance of early diagnosis and treatment 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.